Plain-English translation of NCT03419689 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a research study designed to collect biological samples—including blood, tumor tissue, and other fluids—from people diagnosed with advanced high-grade serous ovarian cancer. Researchers will analyze these samples to discover biomarkers, which are biological signs that could help doctors better understand your cancer and guide future treatment decisions. The information discovered from your samples may help your own doctor make better treatment choices for you.
Ovarian cancer remains difficult to treat, and doctors need better tools to understand each person's cancer and predict which treatments will work best. By studying biological samples from many patients, researchers hope to discover new biomarkers that could improve diagnosis, treatment planning, and outcomes for people with this disease.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will donate blood samples and possibly tumor tissue (either during surgery or from archived tissue samples from a previous procedure). You may also have other fluids collected if needed. The research team will test these samples to look for biomarkers that could help guide your treatment. Your doctor will receive the results and may use them to inform decisions about your care.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Canada